Rhumbline Advisers Alector, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Alector, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 114,004 shares of ALEC stock, worth $218,887. This represents 0.0% of its overall portfolio holdings.

Number of Shares

114,004

Previous 109,924 3.71%

Holding current value

$218,887

Previous $499,000 6.61%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$4.34 - $6.58 $17,707 - $26,846	4,080 Added 3.71%	114,004 $532,000
Q2 2024 Aug 01, 2024	BUY	$4.19 - $6.23 $77,087 - $114,619	18,398 Added 20.1%	109,924 $499,000
Q1 2024 May 09, 2024	BUY	$5.69 - $8.08 $22,350 - $31,738	3,928 Added 4.48%	91,526 $550,000
Q4 2023 Feb 08, 2024	SELL	$3.77 - $8.39 $312 - $696	-83 Reduced 0.09%	87,598 $699,000
Q3 2023 Nov 09, 2023	SELL	$5.2 - $8.77 $15,246 - $25,713	-2,932 Reduced 3.24%	87,681 $568,000
Q2 2023 Aug 08, 2023	BUY	$5.86 - $7.93 $45,596 - $61,703	7,781 Added 9.39%	90,613 $544,000
Q1 2023 May 11, 2023	SELL	$5.85 - $9.84 $2,749 - $4,624	-470 Reduced 0.56%	82,832 $513,000
Q4 2022 Feb 14, 2023	BUY	$6.88 - $9.55 $29,129 - $40,434	4,234 Added 5.35%	83,302 $769,000
Q3 2022 Nov 10, 2022	BUY	$8.19 - $13.2 $30,810 - $49,658	3,762 Added 5.0%	79,068 $748,000
Q2 2022 Aug 11, 2022	BUY	$7.65 - $14.24 $105,830 - $196,996	13,834 Added 22.5%	75,306 $765,000
Q1 2022 May 12, 2022	BUY	$13.02 - $20.78 $22,824 - $36,427	1,753 Added 2.94%	61,472 $876,000
Q4 2021 Feb 10, 2022	SELL	$19.35 - $25.54 $17,531 - $23,139	-906 Reduced 1.49%	59,719 $1.23 Million
Q3 2021 Nov 12, 2021	BUY	$21.65 - $39.49 $55,164 - $100,620	2,548 Added 4.39%	60,625 $1.38 Million
Q2 2021 Aug 05, 2021	BUY	$15.5 - $22.48 $34,813 - $50,490	2,246 Added 4.02%	58,077 $1.21 Million
Q1 2021 May 06, 2021	SELL	$14.84 - $22.23 $59,374 - $88,942	-4,001 Reduced 6.69%	55,831 $1.12 Million
Q4 2020 Feb 10, 2021	BUY	$9.4 - $16.7 $26,508 - $47,094	2,820 Added 4.95%	59,832 $905,000
Q3 2020 Nov 12, 2020	SELL	$10.54 - $24.96 $99,550 - $235,747	-9,445 Reduced 14.21%	57,012 $601,000
Q2 2020 Aug 13, 2020	BUY	$21.87 - $33.11 $494,786 - $749,080	22,624 Added 51.61%	66,457 $1.62 Million
Q1 2020 May 06, 2020	BUY	$16.25 - $35.28 $177,060 - $384,410	10,896 Added 33.08%	43,833 $1.06 Million
Q4 2019 Feb 05, 2020	BUY	$14.17 - $20.3 $15,700 - $22,492	1,108 Added 3.48%	32,937 $568,000
Q3 2019 Oct 23, 2019	BUY	$14.42 - $22.2 $313,144 - $482,095	21,716 Added 214.73%	31,829 $459,000
Q2 2019 Aug 14, 2019	BUY	$16.26 - $26.42 $164,437 - $267,185	10,113 New	10,113 $192,000

Others Institutions Holding ALEC

# of Institutions

168

Shares Held

57.8M

Call Options Held

146K

Put Options Held

90.8K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $159M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Alector, Inc. Transaction History